KALA BIO, Inc.
KALA
$9.31
$0.536.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.23M | -35.65M | -38.51M | -38.96M | -38.72M |
| Total Depreciation and Amortization | 267.00K | 261.00K | 259.00K | 260.00K | 276.00K |
| Total Amortization of Deferred Charges | 980.00K | 1.12M | 1.25M | 1.26M | 1.25M |
| Total Other Non-Cash Items | 9.64M | 9.19M | 9.40M | 9.95M | 3.86M |
| Change in Net Operating Assets | 457.00K | -2.29M | -1.78M | -4.99M | 2.63M |
| Cash from Operations | -25.88M | -27.36M | -29.38M | -32.48M | -30.71M |
| Capital Expenditure | -175.00K | -195.00K | -208.00K | -146.00K | -337.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 10.00M |
| Cash from Investing | -175.00K | -195.00K | -208.00K | -146.00K | 9.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.60M | -5.07M | -5.05M | -18.00K | 0.00 |
| Issuance of Common Stock | 11.69M | 26.66M | 26.66M | 15.56M | 15.60M |
| Repurchase of Common Stock | -162.00K | -162.00K | -162.00K | -162.00K | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 8.54M | 10.50M | 10.50M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -120.00K | -120.00K | -119.00K | -119.00K | -119.00K |
| Cash from Financing | 3.80M | 21.30M | 29.88M | 25.77M | 25.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.26M | -6.26M | 286.00K | -6.86M | 4.94M |